In elderly anticoagulated patients, antidepressants significantly increase 90-day ED revisit risk for gastrointestinal bleeding, with chronic kidney disease and antiplatelet therapy also key risk fact
Do antidepressants, antiplatelet therapy, or chronic kidney disease increase the risk of ED re-visit for gastrointestinal bleeding within 90 days in elderly patients on oral anticoagulants?
Elderly patients with gastrointestinal bleeding secondary to oral anticoagulant therapy
Addition of antidepressants, concomitant antiplatelet therapy, or presence of chronic kidney disease
Emergency department re-visit for gastrointestinal bleeding within 90 dayshard clinical
Concomitant use of antidepressants or antiplatelets, as well as chronic kidney disease, are significant risk factors for 90-day ED revisits due to GI bleeding in elderly patients on oral anticoagulants.
Absolute Event Rate: 0% vs 0%
In elderly patients anticoagulated, the addition of antidepressants significantly increases the risk of ED re-visit for gastrointestinal bleeding within 90 days. Chronic kidney disease and concomitant antiplatelet therapy also emerge as key risk factors.
Building similarity graph...
Analyzing shared references across papers
Loading...
Quintero et al. (Sun,) reported a other. In elderly anticoagulated patients, antidepressants significantly increase 90-day ED revisit risk for gastrointestinal bleeding, with chronic kidney disease and antiplatelet therapy also key risk fact.
synapsesocial.com/papers/69a76139c6e9836116a2ef13 — DOI: https://doi.org/10.1016/j.farma.2025.12.009
Andrea Garrido Quintero
Silvia Lobo
Hospital de Sant Pau
Ruiz Ramos J
Hospital de Sant Pau
Farmacia Hospitalaria
Hospital de Sant Pau
Building similarity graph...
Analyzing shared references across papers
Loading...